| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,493 |
1,321 |
$120K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,326 |
1,190 |
$116K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,690 |
1,490 |
$99K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
673 |
614 |
$83K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
832 |
729 |
$66K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
731 |
659 |
$32K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
310 |
280 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
574 |
531 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
222 |
187 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
318 |
150 |
$5K |
| 87634 |
|
28 |
26 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17 |
15 |
$286.82 |
| 81003 |
|
82 |
76 |
$29.48 |
| 99000 |
|
15 |
13 |
$0.00 |